Related Experiment Video For calcitonin
Updated: Jun 3, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
High Sensitivity of Fine-Needle Aspiration Calcitonin in Detecting Medullary Thyroid Carcinoma Is Independent of
Sium Wolde Sellasie1,2, Stefano Amendola1, Leo Guidobaldi3
1Division of Endocrinology and Diabetes, CTO Andrea Alesini Hospital, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Abstract:
The measurement of Calcitonin (Ctn) in fine-needle aspiration (FNA) washout fluids (FNA-Ctn) has demonstrated excellent sensitivity, significantly higher than FNA cytology, in detecting medullary thyroid carcinoma (MTC). However, the absence of a fixed cutoff value for FNA-Ctn poses a limitation. This study aimed to investigate whether the sensitivity of FNA-Ctn in detecting MTC varies with different cutoffs reported in the literature. A single-centre series of MTCs was retrospectively reviewed. The preoperative FNA-Ctn levels were re-evaluated using various thresholds previously reported in the literature, and the corresponding FNA-Ctn sensitivities were compared. Twenty-one MTCs were included (69% women; median age 59 years; median serum Ctn value 86 pg/mL; median MTC major diameter 10 mm). The median FNA-Ctn value was 2000 pg/mL (interquartile range 49-250). MTCs nodules were assessed at high risk (ACR TI-RADS 5) in 50% of cases, while 47.6% were cytologically malignant. Additionally, 42.9% of cases were assessed as stage III according to Union for International Cancer Control staging system (UICC). Serum Ctn was significantly lower in stage I (p = 0.04). FNA-Ctn was positively correlated with serum Ctn (Rho = 0.45; p = 0.04), while ACR TI-RADS assessment with MTC stage (Rho = 0.69; p = 0.003). FNA-Ctn sensitivity ranged from 95% to 100% based on the previously proposed FNA-Ctn cutoffs. The high sensitivity of FNA-Ctn in detecting MTC did not significantly differ when applying the previously proposed cutoffs. Given the absence of a universally applicable FNA-Ctn decisional threshold, institutions should establish their own diagnostic cutoffs. Future guidelines should incorporate these concepts to enhance clinical decision-making and patient outcomes.

